Mark Talamonti to Neoplasms
This is a "connection" page, showing publications Mark Talamonti has written about Neoplasms.
Connection Strength
0.299
-
Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort. Thromb Res. 2023 09; 229:69-72.
Score: 0.080
-
Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank. Int J Cancer. 2021 04 01; 148(7):1658-1664.
Score: 0.067
-
Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
Score: 0.042
-
Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr; 251(4):708-16.
Score: 0.032
-
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008 Oct 01; 26(28):4626-33.
Score: 0.028
-
Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007 Dec; 14(12):3321-7.
Score: 0.027
-
Society of Surgical Oncology: statement on genetic testing for cancer susceptibilty. Committee on Issues and Governmental Affairs of the Society of Surgical Oncology. Ann Surg Oncol. 1999 Jul-Aug; 6(5):507-9.
Score: 0.015
-
Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011 Apr; 253(4):779-85.
Score: 0.009